Artventive Medical Group, Inc.
ArtVentive Medical Group Inc. is an innovative medical device company focused on developing, manufacturing, and marketing a family of endoluminal occlusion devices, notably the EOS™ Plug, which enables minimally invasive, immediate occlusion of targeted veins, arteries, and other lumens within the body. The company has received CE EU approval in 2013 and FDA clearance in 2014, supporting its global expansion. ArtVentive is committed to improving clinical outcomes, reducing healthcare costs, and providing innovative solutions in vascular embolization.
Industries
Nr. of Employees
small (1-50)
Artventive Medical Group, Inc.
ArtVentive, San Marcos, CA, USA
Patents
Products
Endoluminal occlusion plug system (vascular plug) with delivery catheter
A catheter-deployable occlusion plug system for immediate peripheral vessel occlusion. Features rapid deployment for instantaneous occlusion, design aimed at minimizing imaging artifacts, and multiple sizes to match target vessel diameters.
Endoluminal occlusion demo kit
Professional demonstration kit containing a deployed plug sample, a bare nitinol coil, guiding catheter, deployment handle and syringe for sales and training demonstrations.
Guide catheters and dilators specified for plug delivery
Guide catheters with specified inner diameters, outer diameters, compatible guidewire sizes and working lengths matched to plug sizes to support delivery and deployment.
Endoluminal occlusion plug system (vascular plug) with delivery catheter
A catheter-deployable occlusion plug system for immediate peripheral vessel occlusion. Features rapid deployment for instantaneous occlusion, design aimed at minimizing imaging artifacts, and multiple sizes to match target vessel diameters.
Endoluminal occlusion demo kit
Professional demonstration kit containing a deployed plug sample, a bare nitinol coil, guiding catheter, deployment handle and syringe for sales and training demonstrations.
Guide catheters and dilators specified for plug delivery
Guide catheters with specified inner diameters, outer diameters, compatible guidewire sizes and working lengths matched to plug sizes to support delivery and deployment.
Services
On-site and conference-based hands-on training sessions and demonstrations for interventional radiologists and vascular surgeons to teach device deployment and clinical techniques.
Commercialization services including direct sales to hospitals in the US and coordination with international distribution partners for product availability and training in other regions.
On-site and conference-based hands-on training sessions and demonstrations for interventional radiologists and vascular surgeons to teach device deployment and clinical techniques.
Commercialization services including direct sales to hospitals in the US and coordination with international distribution partners for product availability and training in other regions.
Expertise Areas
- Peripheral vascular embolization
- Medical device R&D for endoluminal occlusion
- Clinical research and post-market clinical surveillance
- Regulatory compliance (CE mark, FDA 510(k)/clearance, national approvals)
Key Technologies
- Endoluminal occlusion plug (expandable membrane-based)
- Catheter-based delivery systems
- Guide catheter and delivery handle mechanics
- Nitinol coil/scaffold components
News & Updates
ArtVentive Successfully Completes Manufacturing transfer
ArtVentive and its manufacturing team have successfully built, tested, and validated manufacturing for its new line of embolization products, supporting the company's growth.
ArtVentive Successfully Completes FDA Audit
ArtVentive has successfully passed its FDA audit, which allows for the commercialization of its EOS™ plugs in the US, EU, and other regions.
2023: ArtVentive EOS-X Transfer into Full Scale Production
Following FDA approval, the company has initiated transfer into full-scale production of its EOS-X product line, which features extended range and reduced delivery profile.
ArtVentive Medical Group, Inc's EOS Obtains Approval in Japan
The EOS™ device received approval in Japan on March 10, 2022.
ArtVentive Medical Group Announces FDA Clearance of EOS-X Endoluminal Occlusion System
FDA clearance was announced on March 7, 2022.
Bill Olson Appointed CEO of ArtVentive Medical Group, Inc.
Bill Olson was appointed CEO on January 3, 2022.
ArtVentive Successfully Completes Manufacturing transfer
ArtVentive and its manufacturing team have successfully built, tested, and validated manufacturing for its new line of embolization products, supporting the company's growth.
ArtVentive Successfully Completes FDA Audit
ArtVentive has successfully passed its FDA audit, which allows for the commercialization of its EOS™ plugs in the US, EU, and other regions.
2023: ArtVentive EOS-X Transfer into Full Scale Production
Following FDA approval, the company has initiated transfer into full-scale production of its EOS-X product line, which features extended range and reduced delivery profile.
ArtVentive Medical Group, Inc's EOS Obtains Approval in Japan
The EOS™ device received approval in Japan on March 10, 2022.
ArtVentive Medical Group Announces FDA Clearance of EOS-X Endoluminal Occlusion System
FDA clearance was announced on March 7, 2022.
Bill Olson Appointed CEO of ArtVentive Medical Group, Inc.
Bill Olson was appointed CEO on January 3, 2022.